SIGN UP FOR UPDATES!
Sign up for Englemed updates from TwitterSign up for Englemed updates from Facebook
ENGLEMED
Contact Englemed
Our contact email address.
We can provide a specialist, tailored health and medical news service for your site.
Click here for more information
RSS graphic XML Graphic Add to Google
About Englemed news services - services and policies.
Englemed News Blog - Ten years and counting.
Diary of a reluctant allergy sufferer - How the British National Health Service deals with allergy.
BOOKS AND GIFTS THIS WAY!
BookshopFor books on women's health, healthy eating ideas, mental health issues, diabetes, etc click here
SEARCH THIS SITE
Google

WWW Englemed
Copyright Notice. All reports, text and layout copyright Englemed Ltd, 52 Perry Avenue, Birmingham UK B42 2NE. Co Registered in England No 7053778 Some photos copyright Englemed Ltd, others may be used with permission of copyright owners.
Disclaimer: Englemed is a news service and does not provide health advice. Advice should be taken from a medical professional or appropriate health professional about any course of treatment or therapy.
FreeDigitalPhotos
www.freedigitalphotos.net
FreeWebPhotos
www.freewebphoto.com
FROM OUR NEWS FEEDS
Heart failure ranked 'less important than potholes'
Tues June 28th - Heart failure is deemed less important than potholes in roads and pavements in the UK, according to an analysis published today. More
Cannabis users' increased risk of hospital admission
Tues June 28th - Canadian researchers have called for curbs on the globally rising levels of recreational cannabis because users have an increased risk of needing emergency care and hospital admission for any cause. More
RECENT COMMENTS
On 09/10/2020 William Haworth wrote:
How long is recovery time after proceedure... on Ablation cuts atrial fibrillat...
On 08/02/2018 David Kelly wrote:
Would you like to write a piece about this to be i... on Researchers unveil new pain re...
On 23/10/2017 Cristina Pereira wrote:
https://epidemicj17.imascientist.org.uk/2017/06/21... on HIV breakthrough - MRC...
On 12/09/2017 Aparna srikantam wrote:
Brilliant finding! indeed a break through in under... on Leprosy research breakthrough...
On 01/07/2017 Annetta wrote:
I have been diagnosed with COPD for over 12 years.... on Seaweed plan for antimicrobial...
OUR CLIENTS
THIS WEEK'S STORIES
ENGLEMED HEALTH NEWS

Cold-activated drug unveiled

Monday April 12th, 2010

Scientists have developed a drug that is only activated in cold temperatures, it has been announced.

The drug has been developed for use during a "freezing" procedure, which is used to protect critically ill patients from harm.

The procedure, known as therapeutic hypothermia, creates a risk of blood clots forming - so Australian scientists say they have now developed a drug that can be used to counteract this.

The discovery was unveiled at the American Heart Association's Arteriosclerosis, Thrombosis and Vascular Biology conference at the weekend.

The drug works at 22C - 71.6F - but stops working when the body reaches a normal temperature of 37C - 98.6F.

So far it has been tested on blood samples in the laboratory.

Hypothermia has been used to help heart surgery for about 50 years and since 2002 has been recommended as a way of helping some patients who suffer heart attack.

Researcher Dr Karlheinz Peter, of Baker IDI Heart & Diabetes Institute in Melbourne, Australia, said: "We used biotechnology to create a modern intelligent drug.

"This drug is tailored for preventing clots during therapeutic hypothermia and for minimising bleeding problems especially after rewarming."

Tags: A&E | Australia | Heart Health | North America | Pharmaceuticals

Printer friendly page Printer friendly page

CATEGORIES